Exclusive Report on Global Clinical Trial Management System Industry: Growth Opportunity | Oracle Corporation (US), Medidata Solutions (US), and Parexel International (US).

The global Clinical Trial Management System market size is expected to reach $2490.1 Million by 2028 growing at the CAGR of 14.04% from 2021 to 2028.

Rise in the number of clinical trials owing to the large demand for novel therapeutic drugs and medical devices drive the growth of the market. Moreover, the increase in prevalence of chronic diseases, surge in the trend of outsourcing of clinical trials, and increase in awareness regarding the benefits of using CTM fuels the growth of the market. However, high cost associated with CTM and dearth of skilled professionals hamper demand growth.

Request Free Sample Report or PDF Copy: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=005494

Key Players

Some of the major Clinical Trial Management System players holding high market share include Oracle Corporation (US), Medidata Solutions (US), and Parexel International (US). These players use partnership and collaboration as a key strategy to gain significant market share to compete with market leaders.

The key players profiled in the report are:
● Oracle Corporation (US)
● Medidata Solutions (US)
● Parexel International (US)
● BIOCLINICA (US)
● IBM (US)
● Bio-Optronics (US)
● Datatrak (US)
● Veeva Systems (US)
● DSG (US)
● MasterControl (US)

The recently published research report on Global Clinical Trial Management System Market by Evolve Business Intelligence examines the industry in the context of major market aspects including market size & forecast, market shares in terms of revenues and volume, key players, and SWOT analysis. The market is analyzed based on 4 separate indications in the market dynamic chapter: Drivers, Restraints, Key Trends, and Challenges. The total sum of these sections will help you understand what strategies will be best to adopt in order to prosper through this industry over a few short years. The quantitative analysis includes our actual findings out of this research study where we provided additional insight into what our readers can do to embrace new opportunities or plan against threats that might hinder the market.

The COVID-19 pandemic has led to disruption in the supply chain leading to lower demand or supply shortages in the Clinical Trial Management System market. The travel restrictions and social-distancing measures have resulted in a sharp drop in consumer and business spending and this pattern is expected to continue for some time. The end-user trend and preferences have changed due to the pandemic and have resulted in manufacturers, developers, and service providers adopting various strategies to stabilize the company.

The New Normal

As businesses recover from the COVID-19 pandemic, they have a new set of priorities to cope with. Throughout this crisis, they were forced to deal with shifting situations and often fell short of their ultimate goals. Now that a cure has been found and the pandemic is dying down, they will need to recuperate from this epidemic by setting forth new objectives to succeed in the future.

In terms of COVID 19 impact, the Clinical Trial Management System market report also includes the following data points:
● COVID19 Impact on Clinical Trial Management System market size
● End-User/Industry/Application Trend, and Preferences
● Government Policies/Regulatory Framework
● Key Players Strategy to Tackle Negative Impact/Post-COVID Strategies
● Opportunity in Clinical Trial Management System market

Segmental Analysis

Market Segment By Product Type with focus on market share, consumption trend, and growth rate of Clinical Trial Management System Market:
o Software
o Services

Market Segment By End User with the focus on market share, consumption trend, and growth rate of Clinical Trial Management System Market:
o Medical Device Manufacturers
o Small & Mid-sized Pharma-biotech Companies
o CROs
o Large Pharma-biotech Companies
o Other

For more information: https://evolvebi.com/product/clinical-trial-management-system-market-analysis-and-global-forecast-2021-2028-with-covid-impact-analysis/

Key Region/ Countries Covered
● North America (US, Canada, Mexico)
● Europe (Germany, U.K., France, Italy, Russia, Rest of Europe)
● Asia-Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
● Rest of the World (the Middle East & Africa and South America)

Asia Pacific region is expected to have the highest growth in the clinical trial management system market during the forecast period. Increasing government funding to support clinical trials, presence of less stringent regulatory guidelines as compared to developed nations, increasing patient base, faster rate of patient recruitment for clinical trials than mature nations, low operating costs for conducting clinical trials, shortage of trial volunteers in Europe and North America are some of the major factors driving Asia Pacific region’s growth.

Address
Evolve Business Intelligence
C-218, 2nd floor, M-Cube
Gujarat 396191
India
Contact: +1 773 644 5507 / +91 635 396 3987
Email: sales@evolvebi.com
Website: https://evolvebi.com/

About EvolveBI
Evolve Business Intelligence is a market research, business intelligence, and advisory firm providing innovative solutions to challenging the pain points of a business. Our market research reports include data useful to micro, small, medium, and large-scale enterprises. We provide solutions ranging from mere data collection to business advisory.
Evolve Business Intelligence is built on account of technology advancement providing highly accurate data through our in-house AI-modelled data analysis and forecast tool – EvolveBI. This tool tracks real-time data including, quarter performance, annual performance, and recent developments from fortune’s global 2000 companies

This release was published on openPR.